STOCK TITAN

Evofem Biosciences to Participate in Stifel 2021 Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Evofem Biosciences (NASDAQ: EVFM) announced that CEO Saundra Pelletier will participate in the Stifel 2021 Virtual Healthcare Conference on November 16, 2021, at 1:20 p.m. ET. The event will feature a fireside chat format in Track 2. Interested parties can access a live and archived webcast on the company’s website. Evofem is focused on women's reproductive health, with its FDA-approved product, Phexxi®, being a hormone-free contraceptive. One-on-one meetings can be arranged through Stifel for attendees.

Positive
  • None.
Negative
  • None.

SAN DIEGO, Nov. 4, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that Chief Executive Officer Saundra Pelletier will participate in the Stifel 2021 Virtual Healthcare Conference as follows:

Date

Tuesday, November 16, 2021

Time

1:20 p.m. ET

Format

Fireside Chat

Room

Track 2

Webcast (live and replay)

https://wsw.com/webcast/stifel58/evfm/2096280

The webcast will be archived in the Events and Presentations section of the Company's website at https://evofem.investorroom.com/Stifel2021.

Additionally, Evofem Biosciences will host one-on-one meetings on Tuesday, November 16, 2021. Meetings can be requested exclusively via Stifel.

About Evofem Biosciences
Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (chlamydia and gonorrhea). The Company's first FDA-approved product, Phexxi® (lactic acid, citric acid and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of 12 pre-filled applicators and is applied 0-60 minutes before each act of sex. Learn more at phexxi.com and evofem.com.

Phexxi® is a registered trademark of Evofem Biosciences, Inc.

Investor Relations Contact
Amy Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
Mobile: (917) 673-5775

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/evofem-biosciences-to-participate-in-stifel-2021-virtual-healthcare-conference-301416407.html

SOURCE Evofem Biosciences, Inc.

FAQ

When is Evofem Biosciences participating in the Stifel 2021 Virtual Healthcare Conference?

Evofem Biosciences will participate on November 16, 2021.

What time will Evofem’s CEO speak at the Stifel Conference?

The presentation will be at 1:20 p.m. ET.

How can I access the Evofem conference webcast?

The webcast will be available live and archived on the Evofem website.

What is the focus of Evofem Biosciences?

Evofem is dedicated to women's sexual and reproductive health.

What product does Evofem Biosciences offer?

Evofem's FDA-approved product is Phexxi®, a hormone-free contraceptive.

EVOFEM BIOSCIENCE INC

OTC:EVFM

EVFM Rankings

EVFM Latest News

EVFM Stock Data

1.30M
100.33M
0%
0.1%
10.98%
Biotechnology
Healthcare
Link
United States of America
San Diego